Dr Hilary Jones says the results from trials of ipilimumab and nivolumab on cancer patients are very exciting and much more promising than previous tests. Report by Fudgea. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
